Adherence and Persistence to Inclisiran Among Early Users in Germany

Novartis

Status: Completed

Conditions: High Levels of Low-density Lipoprotein Cholesterol

Study type: Observational

Funder types: Industry

Identifiers

NCT05870657

CKJX839A12013

Details and patient eligibility

About

The present study was a descriptive, non-interventional, retrospective cohort study aimed at evaluating early data on adherence, persistence, and treatment patterns among patients receiving inclisiran and other lipid-lowering therapies (LLT) in a real-world setting in Germany. Analysis was carried out using the IQVIA™ LRx database.

Enrollment: 1,109 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Study subjects ≥18 years old who were prescribed an inclisiran dose.

Exclusion criteria

None

Trial design

1,109 participants in 1 patient group

Overall cohort

Description:

Patients receiving inclisiran